Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity

Kimberly R Byrnes1, Bogdan Stoica, David J Loane

  • 1Department of Neuroscience, Georgetown University Medical Center, 3970 Reservoir Road N.W., Washington, DC 20057, USA. krb27@georgetown.edu

Glia
|September 26, 2008
PubMed

Insights

Activating metabotropic glutamate receptor 5 (mGluR5) in microglia reduces neuroinflammation and neurotoxicity. This finding suggests mGluR5 as a potential therapeutic target for neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Microglia play crucial roles in neuroinflammation and neurodegenerative disorders.
  • The role of Group I metabotropic glutamate receptor 5 (mGluR5) in microglial function remains largely uncharacterized.
  • Previous studies indicate expression of other mGluR groups in microglia, influencing their activation.

Purpose of the Study:

  • To investigate the expression and function of mGluR5 in primary microglial cells.
  • To determine if mGluR5 activation modulates microglial activation and associated neurotoxicity.
  • To elucidate the signaling pathways involved in mGluR5-mediated effects in microglia.

Main Methods:

  • Immunocytochemistry and Western blot to confirm mGluR5 expression in microglial cultures.
  • Stimulation of microglial cells with lipopolysaccharide (LPS) to induce activation.
  • Treatment with the selective mGluR5 agonist (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) and measurement of inflammatory markers.
  • Utilized mGluR5 knockout mice and selective antagonists to confirm receptor specificity.
  • Investigated downstream signaling pathways using phospholipase C, protein kinase C inhibitors, and calcium chelators.

Main Results:

  • mGluR5 protein is expressed in primary microglial cultures.
  • CHPG treatment significantly reduced LPS-induced production of nitric oxide, reactive oxygen species, and TNFalpha.
  • CHPG administration attenuated microglial-induced neurotoxicity.
  • The anti-inflammatory effects of CHPG were dependent on mGluR5 expression and were blocked by antagonists.
  • mGluR5 activation in microglia involves the G(alphaq)-protein signal transduction pathway, including phospholipase C, protein kinase C, and calcium signaling.

Conclusions:

  • Microglial mGluR5 is expressed and functionally active.
  • Activation of microglial mGluR5 exerts potent anti-inflammatory and neuroprotective effects.
  • Microglial mGluR5 represents a promising novel therapeutic target for neuroinflammatory and neurodegenerative conditions.